Početna › Neuroblastom › Arkansas
Kliničke studije za Neuroblastom u državi Arkansas
6 studija za Neuroblastom traži sudionike na lokacijama u državi Arkansas.
Gradovi u državi Arkansas
Službeni tekst studije (engleski)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Arkansas Children's Hospital, Little Rock
U tijeku regrutacijaFaza 3
Do 30 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06172296Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Arkansas Children's Hospital, Little Rock
U tijeku regrutacijaFaza 2
Do 22 godina · Oba spola · Ažurirano 4. ruj 2026. · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Arkansas Children's Hospital, Little Rock
U tijeku regrutacijaFaza 1/2
Do 26 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06465199Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Arkansas Children's Hospital, Little Rock
U tijeku regrutacijaFaza 2
Od 1 do 21 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06540963Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Arkansas Children's Hospital, Little Rock
U tijeku regrutacijaFaza 3
365 Days – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT03126916Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Arkansas Children's Hospital, Little Rock
U tijeku regrutacijaFaza 2
12 Months – 21 Years · Oba spola · Ažurirano 12. kol 2026. · NCT05489887Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.